caffeine has been researched along with azacitidine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hradecná, Z; Kittler, L; Löber, G | 1 |
| Ihara, T; Kurishita, A | 2 |
| Kurishita, A | 1 |
| Adams, EG; Bhuyan, BK; Folz, BA; Smith, KS | 1 |
| Akar, AR; Akcali, KC; Ayaloglu-Butun, F; Durdu, S; Ozyurda, U; Terzioglu-Kara, E; Tokcaer-Keskin, Z; Ugur, M | 1 |
| Hu, WY; Li, X; Li, XP; Ren, H; Shen, W; Tang, KF; Tian, L; Wang, F; Wu, JF; Yang, M; Zeng, GL | 1 |
1 review(s) available for caffeine and azacitidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for caffeine and azacitidine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Photochemistry and photobiology of 5-azacytidine: effect of repair on photostabilization of Escherichia coli.
Topics: Acriflavine; Azacitidine; Caffeine; Darkness; DNA Repair; DNA, Bacterial; Escherichia coli; Ultraviolet Rays | 1978 |
Hyperploid cells in the limb buds of rats and 5-azacytidine-induced digital deformities.
Topics: Abnormalities, Drug-Induced; Animals; Azacitidine; Caffeine; Female; Hindlimb; Humans; Male; Polyploidy; Rats; Rats, Inbred Strains; Specific Pathogen-Free Organisms; Toes | 1991 |
Inhibitory effect of caffeine on 5-azacytidine-induced digital malformations in the rat.
Topics: Abnormalities, Drug-Induced; Animals; Azacitidine; Caffeine; Dose-Response Relationship, Drug; Female; Fetal Death; Limb Deformities, Congenital; Methylation; Pregnancy; Rats | 1987 |
Histological study of cell death in digital malformations induced by 5-azacytidine: suppressive effect of caffeine.
Topics: Abnormalities, Drug-Induced; Animals; Azacitidine; Caffeine; Cell Survival; Dose-Response Relationship, Drug; Embryo, Mammalian; Hindlimb; Rats; Rats, Inbred Strains; Time Factors | 1989 |
Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aphidicolin; Azacitidine; Benzofurans; Caffeine; Cell Survival; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Cyclohexanecarboxylic Acids; Cyclohexenes; Decitabine; Deoxyadenosines; DNA; Dose-Response Relationship, Drug; Drug Synergism; Duocarmycins; Indoles; Melanoma, Experimental; Melphalan; Mutagens; Organoplatinum Compounds; Pentoxifylline; Tumor Cells, Cultured | 1995 |
Timing of induction of cardiomyocyte differentiation for in vitro cultured mesenchymal stem cells: a perspective for emergencies.
Topics: Animals; Antigens, CD34; Azacitidine; Biomarkers; Bone Marrow Cells; Caffeine; Calcium; Cell Differentiation; Cell Lineage; Cell Proliferation; Cells, Cultured; Female; Membrane Potentials; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocytes, Cardiac; Potassium Chloride; Rats; Rats, Sprague-Dawley; Thy-1 Antigens; Time Factors | 2009 |
[Up-regulation of major histocompatibility complex class I-related molecules A (MICA) induced by 5-aza-2'-deoxycytidine].
Topics: Ataxia Telangiectasia Mutated Proteins; Azacitidine; Caffeine; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line; Cell Membrane; Decitabine; DNA Damage; DNA-Binding Proteins; Flow Cytometry; Hep G2 Cells; Hepatocytes; Histocompatibility Antigens Class I; Humans; Liver Neoplasms; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Suppressor Proteins; Up-Regulation | 2009 |